CN105944048B - 一种用于贴敷治疗骨关节炎的中药散剂 - Google Patents
一种用于贴敷治疗骨关节炎的中药散剂 Download PDFInfo
- Publication number
- CN105944048B CN105944048B CN201610271425.5A CN201610271425A CN105944048B CN 105944048 B CN105944048 B CN 105944048B CN 201610271425 A CN201610271425 A CN 201610271425A CN 105944048 B CN105944048 B CN 105944048B
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- medicine
- rhizoma
- application treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 95
- 238000011282 treatment Methods 0.000 title claims abstract description 64
- 201000008482 osteoarthritis Diseases 0.000 title claims abstract description 48
- 239000000843 powder Substances 0.000 title claims abstract description 33
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 23
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 22
- 235000008397 ginger Nutrition 0.000 claims abstract description 22
- 244000226566 Psoralea corylifolia Species 0.000 claims abstract description 15
- 210000000582 semen Anatomy 0.000 claims abstract description 14
- 241000255791 Bombyx Species 0.000 claims abstract description 13
- 235000003392 Curcuma domestica Nutrition 0.000 claims abstract description 13
- 241000123589 Dipsacus Species 0.000 claims abstract description 13
- 244000153234 Hibiscus abelmoschus Species 0.000 claims abstract description 13
- 241000283966 Pholidota <mammal> Species 0.000 claims abstract description 13
- 241000132171 Phryma leptostachya Species 0.000 claims abstract description 13
- 241000736246 Pyrola Species 0.000 claims abstract description 13
- 235000003373 curcuma longa Nutrition 0.000 claims abstract description 13
- 235000013976 turmeric Nutrition 0.000 claims abstract description 13
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 12
- 241000218176 Corydalis Species 0.000 claims abstract description 11
- 244000008991 Curcuma longa Species 0.000 claims abstract 5
- 241000234314 Zingiber Species 0.000 claims description 21
- 239000002994 raw material Substances 0.000 claims description 8
- 230000002035 prolonged effect Effects 0.000 claims 3
- 229940079593 drug Drugs 0.000 abstract description 33
- 230000000694 effects Effects 0.000 abstract description 30
- 210000000988 bone and bone Anatomy 0.000 abstract description 23
- 239000008280 blood Substances 0.000 abstract description 20
- 210000004369 blood Anatomy 0.000 abstract description 19
- 238000005728 strengthening Methods 0.000 abstract description 16
- 206010036790 Productive cough Diseases 0.000 abstract description 6
- 208000024794 sputum Diseases 0.000 abstract description 6
- 210000003802 sputum Anatomy 0.000 abstract description 6
- 244000273928 Zingiber officinale Species 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 description 35
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 23
- 201000010099 disease Diseases 0.000 description 22
- 208000002193 Pain Diseases 0.000 description 21
- 230000036407 pain Effects 0.000 description 21
- 210000004185 liver Anatomy 0.000 description 16
- 238000000034 method Methods 0.000 description 15
- 210000003205 muscle Anatomy 0.000 description 15
- 230000008901 benefit Effects 0.000 description 9
- 210000001624 hip Anatomy 0.000 description 9
- 210000003127 knee Anatomy 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 9
- 208000006820 Arthralgia Diseases 0.000 description 8
- 244000163122 Curcuma domestica Species 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 108010074051 C-Reactive Protein Proteins 0.000 description 7
- 102100032752 C-reactive protein Human genes 0.000 description 7
- 238000001467 acupuncture Methods 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- CVCQAQVBOPNTFI-AAONGDSNSA-N (3r,4r,5s,6r)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol;sulfuric acid Chemical compound OS(O)(=O)=O.N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O.N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O CVCQAQVBOPNTFI-AAONGDSNSA-N 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 231100001274 therapeutic index Toxicity 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 230000003213 activating effect Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000002146 bilateral effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 230000008407 joint function Effects 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000002203 pretreatment Methods 0.000 description 3
- 230000037452 priming Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 210000002435 tendon Anatomy 0.000 description 3
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000000593 degrading effect Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- USDAQJSRGJCNNX-JJKGCWMISA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanamide;sulfuric acid Chemical compound OS(O)(=O)=O.NC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO USDAQJSRGJCNNX-JJKGCWMISA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- UIAGMCDKSXEBJQ-IBGZPJMESA-N 3-o-(2-methoxyethyl) 5-o-propan-2-yl (4s)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)[C@H]1C1=CC=CC([N+]([O-])=O)=C1 UIAGMCDKSXEBJQ-IBGZPJMESA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical group CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 241001269238 Data Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010016326 Feeling cold Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 244000236658 Paeonia lactiflora Species 0.000 description 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 description 1
- 206010033425 Pain in extremity Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 244000178320 Vaccaria pyramidata Species 0.000 description 1
- 235000010587 Vaccaria pyramidata Nutrition 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 210000001188 articular cartilage Anatomy 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000009432 erxian tang Substances 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000003832 immune regulation Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010832 independent-sample T-test Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 208000018937 joint inflammation Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 229960000715 nimodipine Drugs 0.000 description 1
- 238000013546 non-drug therapy Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000003349 osteoarthritic effect Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 238000010831 paired-sample T-test Methods 0.000 description 1
- 210000004417 patella Anatomy 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000001020 rhythmical effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 235000019600 saltiness Nutrition 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 239000004577 thatch Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 229940126702 topical medication Drugs 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
- A61K36/296—Epimedium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/487—Psoralea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/52—Juglandaceae (Walnut family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8884—Arisaema, e.g. Jack in the pulpit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Insects & Arthropods (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及中医药技术领域,尤其涉及一种用于贴敷治疗骨关节炎的中药散剂。本发明的用于贴敷治疗骨关节炎的中药散剂,是由如下重量份数的成分组成的:鹿衔草15~20份、杜仲10~15份、续断10~15份,狗脊10~15份、补骨脂15~20份、山茱萸10~15份、熟地15~20份、仙茅10~15份、仙灵脾15~20份、胡桃肉10~15份、透骨草20~30份、姜黄8~10份、制南星8~10份、延胡索10~15份、僵蚕10~15份、穿山甲10~15份、当归15~20份、白芍10~20份、姜汁20~30份、麝香0.3~0.5份。本发明提供的用于贴敷治疗骨关节炎的中药散剂,具有补肾壮骨,化痰行瘀,祛风通络的功效,且能够明显减轻患者痛苦,改善关节功能,有效减少患者的经济负担。
Description
技术领域
本发明涉及中医药技术领域,尤其涉及一种用于贴敷治疗骨关节炎的中药散剂。
背景技术
骨关节炎是一种退行性疾病,表现为关节软骨进行性消失,骨质过度增生,临床常见慢性关节疼痛、僵硬、肥大、活动受限等症状。一般认为与衰老、创伤、炎症、肥胖、代谢障碍和遗传等因素有关。于春秋季季节变化时,该病的发病率及复发率明显高于其他季节。发病人群以50岁以上的中老年人为多。我国的骨关节炎患者大约有1亿人,65岁以上约90%的女性和80%的男性均患有不同程度的骨关节炎,此病不但严重地影响着患者的生活质量,也给家庭和社会带来了沉重的经济负担。骨关节炎常发生的部位多为负重的关节,膝骨关节炎最为常见。
骨关节炎属中医“痹证”范畴,中医历代医籍将其称为“骨痹”、“膝痹”、“历节”、“鹤膝风”等。老年人肾精不足,多因感寒、劳累而发病。临床表现为关节疼痛,恶风怕冷,严重者活动受限。西医目前治疗骨关节炎以减轻或消除疼痛,改善或恢复关节功能,提高生活质量为主要目的。治疗一般按非药物疗法,局部药物治疗,全身药物治疗,手术治疗顺序原则进行。2007版中国骨关节炎诊疗指南中强调了用药的安全性,尤其是非选择性非甾体抗炎药导致消化道出血及选择性非甾体抗炎药的心血管风险。因此从安全、有效角度考虑,首选外用药物治疗方法。
中医外治法历史悠久,是中医治疗骨关节炎的一个重要手段,通过改善局部血液循环,缓解局部炎症,降低骨内压等环节,达到保护软骨组织治疗骨关节炎的目的,具有作用直接,起效快,疗效好,不良反应轻微等特点。穴位贴敷给药就是外治法的一种。
现代医学研究表明:穴位给药的生物利用度明显高于一般给药,因腧穴对药物具有敏感性和放大效应,通过药物对皮肤的刺激引起皮肤和患部的血管扩张,促进局部和周身的血液循环,增强新陈代谢,改善局部组织营养。此外,穴位贴敷还可刺激皮肤的神经末梢感受器,通过神经系统形成新的反射,从而破坏原有的病理反射联系。
从现代透皮制剂给药方式看,敷贴外治法有以下特点:(1)不经消化系统的破坏和肝脏的分解;(2)提供较长时间而稳定的药物作用时间;(3)药物可随时停止进入体内;(4)由于皮肤局部吸收,可以使血药浓度稳定;(5)配合选穴给药,其作用是一般贴剂所难以达到的。
“春、秋分风湿免疫贴”贴敷是一种具有穴位贴敷和药物治疗双重作用的治疗方法,并结合四时阴阳消长变化规律,采用穴位贴敷的方法结合现代医学人体免疫学理论,总结多位名老中医数十年临床实践经验,在春秋季对骨关节炎进行治疗,是一种有效的外治方法。
对于“春·秋分风湿免疫贴”穴位贴敷法的作用机理目前认为有两种途径。其一:经络的作用。病有从外入,有从内生,但都离不开经络之地面-十二皮部,而穴位又循序分布于十四经脉之上,药切皮肤穴位之上,药气速到经脉,摄于体内而达到病所,故贴敷用药,实本于针灸经络穴位治病之理,法虽异而其理则一。其二:贴敷之药物的作用。敷贴药物,切近皮肤,彻于肉理,如同内服药物在肠胃内分清别浊,能将药之气味透过皮肤直到经脉摄于体内,融化于津液之中,具有内外一贯之妙,正如《理瀹骈文》所说的“切于皮肤,彻于肉理,摄于吸气,融于津液”。随其用药,能祛邪,拔毒气之外出,抑邪气以内消;能扶正,通营卫,调升降,理阴阳,安五脏,挫折五郁之气,而资化源。基于以上两点,穴位贴敷疗法可收到穴效、药效的双重效应。
发明内容
针对上述问题,本发明提供一种配伍关系明确、实际针对性强、疗效确切显著的用于贴敷治疗骨关节炎的中药散剂。
为实现本发明的上述目的,本发明提供一种用于贴敷治疗骨关节炎的中药散剂,是由如下重量份数的原料组成:鹿衔草15~20份、杜仲10~15份、续断10~15份,狗脊10~15份、补骨脂15~20份、山茱萸10~15份、熟地15~20份、仙茅10~15份、仙灵脾15~20份、胡桃肉10~15份、透骨草20~30份、姜黄8~10份、制南星8~10份、延胡索10~15份、僵蚕10~15份、穿山甲10~15份、当归15~20份、白芍10~20份、姜汁20~30份、麝香0.3~0.5份。
本发明的另一个目的,还提供了一种用于贴敷治疗骨关节炎的中药散剂的制备方法,具体步骤如下。
步骤1、将所述原料鹿衔草、杜仲、续断、狗脊、补骨脂、山茱萸、熟地、仙茅、仙灵脾、胡桃肉、透骨草、姜黄、制南星、延胡索、僵蚕、穿山甲、当归、白芍按重量份数混合研磨成细粉,过100目筛,得药粉混匀备用。
步骤2、采用姜汁、水和步骤(1)中所述的药粉调成糊状,备用,所述姜汁与水的总和与药粉的重量份数比为1:6。
步骤3、将所述药糊抹在空白药贴上形成直径为3cm的圆形,抹药厚度为0.5cm,药物中间放麝香,即得用于贴敷治疗骨关节炎的中药散剂。
所述姜汁为纯姜汁,其浓度为水与纯姜汁总和的30%。
本发明所述的用于贴敷治疗骨关节炎的中药散剂的使用方法:(1)将制备好的治疗骨关节炎的中药散剂,贴敷于外关、命门、腰阳关、肾俞、足三里穴位;(2)春分、秋分节气各15日,每5日1次,每次贴敷6-8小时,每个节气贴5次,春分秋分两个节气为一个疗程。
本发明选取的原料中药材,性味及药效作用分别是:
鹿衔草:味甘、苦、性微温。归肝、肾经。《滇南本草》:“添精补髓,延年益寿。治筋骨疼痛、痰火之证,煎点水酒服。”《安徽志》“性益阳,强筋,健骨,补腰肾,生津液。”本品可用于肾虚腰腿痛、筋骨痿软、风湿痹痛的治疗。
熟地:甘温质润,是补肾填精益髓的要药,如《本草从新》载:“滋肾水,封填骨髓,利血脉,补益真阴,聪耳明目,黑发乌须……一切肝肾阴亏,虚损百病,为壮水之主药。”肾精得以充养,则肾气旺盛,肾气属阳,有助于肾阳的恢复。有医家认为该药具有“阴中求阳”之效。
杜仲:甘、微辛,性温。具有补肝肾、强筋骨、益腰膝之功能,走经络关节、筋脉气血之间,强筋骨之力较强。
补骨脂:辛、苦、温,归肾、脾经,《本草经疏》:补骨脂,能暖水脏,阴中生阳,壮火益土之要药也。
胡桃肉:甘温,入肾、肺、大肠经。治疗肾气虚弱,腰痛如折,或腰间似有物后果坠,起从艰辛者。
杜仲、补骨脂、胡桃仁三药为青莪丸的主要药物,主要用于治疗肾虚腰痛,起坐不利,膝软乏力。
续断:味苦、辛、性微温。主要功能为补肝肾、续筋骨,通血脉、利关节。与杜仲常二药合用,此药入肾经血分,偏治腰膝腿足疼痛,兼能活血。杜仲入肾经气分,偏治腰膝酸痛。
狗脊:味苦、甘、性温。兼入肾督,为强筋骨之要药,能补肝肾,强筋骨、祛风湿、利关节,用于治疗肝肾不足,风湿日久、腰背酸痛、屈伸不利等症。
山茱萸:味酸、涩,性微温。归肝肾药。功用为补肝肾,强身体,是常用的滋补强壮骨。
仙茅:辛、温、有毒,入肝肾经,具有温肾壮阳,祛除寒湿之功效。主治腰膝酸痛、筋骨软弱、下肢拘挛等症。
仙灵脾:辛、温、无毒,入肝、肾二经,具有补肾壮阳、祛风除湿。《药性论》:“主坚筋益骨。”《日华子本草》记载其“治一切冷风劳气,补腰膝,强心力,……筋骨挛急,四肢不任,老人昏髦,中年健矿。”《本草纲目》记载仙灵脾“益精气,坚筋骨,补腰膝,强心力”之功效。
透骨草:辛散胜湿,祛风散寒,舒筋活络。《本草纲目》指出:“治筋骨一切风湿疼痛挛缩”。
当归:味甘而重,故专能补血,其气轻而辛,故又能行血,补中有动,行中有补;现代药理当归对免疫功能低下的机体有免疫调解和恢复作用。
白芍:苦、酸、微寒,归肝、脾经,《别录》:“通顺血脉,缓中,散恶血,逐贼血,去水气,利膀胱、大小肠,消痈肿。”
姜黄:辛散苦燥温通,可外散风寒湿邪,内行气血,通经消肿止痛,尤长于行肢臂而除痹痛。
制南星:味苦、辛,性温,有毒。能燥痰,祛经络中的风痰。
僵蚕:味咸、辛,性平。主要功能祛风解痉,消痰散结。与制南星合用,可消经络、关节中顽痰。
延胡索:又名元胡,味辛、微苦,性温。主要功能为活血行气。前人认为它能“行血中气滞,气中血滞”。通过活血行气而能治一身上下、心腹、腰膝、内外各种疼痛。
穿山甲:味咸性微寒,具有通经络、活瘀血、消痈肿之功效,偏走全身、无处不到,可通经络,引药直达病所。
生姜汁:辛、温,归肺、脾、胃经,鲜汁性劲,散寒温经,东垣言“能行阳而散气”、“通四肢关节,开五脏六腑”。
麝香:辛、温,归心、脾经,活血通强,消肿止痛,其为辛香走窜之品,引药透达。《仁斋直指方》言:“通诸窍,开经络,透肌骨”;《本草纲目》也指出“化阳通腠理”。
方中诸药合用,组成了一剂补肾壮骨、化痰行瘀、通络止痛的良方。
本发明组方配伍释义:骨关节炎多发生于50岁以上的中老年人,随年龄的增长其发病率在逐年上升,又称退行性关节炎。其发病不外乎外感风寒湿邪,内伤于肝肾不足,气血失和或跌仆损伤,使气血运行不畅,络脉阻滞不通,病久则肝肾两亏,筋软骨痿,而至关节功能障碍。在疾病的过程中,气血不畅,经络不通,日久形成痰浊、瘀血等病理产物,导致疾病缠绵难愈。因此治疗上以补肾壮骨治本,化痰行瘀,通络止痛以治标。
方中组方分析:杜仲、续断、鹿衔草、胡桃肉均入肾经,具有补肝肾、续筋骨,通血脉、利关节之功效,共为君药。狗脊、补骨脂、山茱萸、熟地、当归、白芍为臣药,补肾壮骨,益肾填精,加强君药补肾壮骨之作用;仙茅、仙灵脾为二仙汤的主药,具有补肾壮阳之作用,同为臣药。佐助药为两组,一组透骨草、姜黄两者均善于祛风除湿,通经活络,治疗风湿痹痛。制南星、僵蚕化痰通络、祛除关节经络中痰浊,延胡索活血行气治疗一身关节疼痛,穿山甲通经活血,走全身经络,引药直达病所。姜汁具有祛风散寒之作用,可增加其他药物透皮吸收,麝香引经达病所。
取穴主要根据病所的经络循行部位选穴,旨在疏通经络气血的阻滞,使营卫调和则风寒湿无所依附而痛痹遂解。腧穴作为脏腑气血汇聚之处,对药物具有储存和放大作用。当药物经过经络腧穴吸收、传输和利用的同时,其作用已不仅仅是两者功效简单的叠加,而是两者相互激发、相互协同而产生的整体效应,可以取得在通常情况下单纯用药或针灸所不能达到的疗效。
春分、秋分是二十四节气中的两个节气,春分为春夏之交,秋分为秋冬之交。采用春、秋分进行贴敷是与四季阴阳消长变化规律相符合,以阳气为例,夏季阳气盛极而转秋季渐衰,冬季阳气衰竭而转春季渐生,阴阳转化体现在夏秋和冬春两季。对于骨关节炎患者来说,由于阴阳转化,节律变动剧烈,稍不注意即可因不能同步适应而生病变,故春夏之交、秋冬之交患病者较多,是疾病的好发季节,更有人曾对骨关节炎起病年节律进行深入研究,发现各此病均以春季3-5月、初夏6月为起病高峰,以及骨关节炎由秋至冬、病情逐渐加剧的季节性规律特点。因此,我们认为一年二十四节气中二分(春分、秋分)是阴阳平衡点,人身之阴阳处于平衡状态,选择在春、秋分进行贴敷,可以调节人体阴阳水平,使之处于高水平状态,扶助正气,既能治疗骨关节炎,又能防止此病的发生。
与现有技术相比本发明的有益效果。
本发明提供的一种用于贴敷治疗骨关节炎的中药散剂,根据中医药理论,将原料中药按一定比例进行组方,符合中药的配伍原则,可以增强各成分的原有药效,使各成分相辅相成,具有补肾壮骨,化痰行瘀,祛风通络的功效,且能够明显减轻患者痛苦,改善关节功能,有效减少患者的经济负担。本发明根据四时阴阳消长变化规律与穴位贴敷理论结合现代医学人体免疫学理论,采用中药外用穴位贴敷手段,在春分、秋分两个节气对骨关节炎进行治疗,通过“药穴双效”发挥作用,从而达到治疗骨关节炎的目的。
具体实施方式
本实施例提供的用于贴敷治疗骨关节炎的中药散剂,是由以下重量份数的中药组成的:鹿衔草15份、杜仲12份、续断12份,狗脊10份、补骨脂15份、山茱萸10份、熟地15份、仙茅13份、仙灵脾15份、胡桃肉13份、透骨草20份、姜黄9份、制南星8份、延胡索10份、僵蚕15份、穿山甲10份、当归15份、白芍20份、姜汁20份、麝香0.3份。
本发明治疗骨关节炎的外用中药制剂的制备方法,具体步骤如下。
步骤1、将所述中药(鹿衔草、杜仲、续断、狗脊、补骨脂、山茱萸、熟地、仙茅、仙灵脾、胡桃肉、透骨草、姜黄、制南星、延胡索、僵蚕、穿山甲、当归、白芍)混合研磨成细粉,过100目筛,得药粉混匀备用。
步骤2、采用姜汁、水和所述药粉调成糊状,得药糊备用,所述姜汁与水的总和与药粉的重量份数比为1:6,所述姜汁为纯姜汁,其纯姜汁浓度占水和纯姜汁总和的30%。
步骤3、将所述药糊抹在空白药贴上形成直径为3cm的圆形,抹药厚度为0.5cm,药物中间放0.3份麝香,即得用于贴敷治疗骨关节炎的中药散剂。
本发明治疗骨关节炎的外用中药制剂的使用方法:(1)外用,将制备好的用于贴敷治疗骨关节炎的中药散剂,贴敷于外关、肾俞、命门、腰阳关、足三里穴位。(2)春分、秋分节气各15日,每5日1次,每个节气贴5次,春分秋分两个节气为一个疗程。
临床资料。
1.资料与方法。
1.1一般资料。
自2011年01月-2015年12月辽宁中医药大学附属医院门诊及病房住院的骨关节炎(中医诊断痹证)患者507例,男225例,女282例;年龄最大83岁,最小45岁,平均65.3岁;病程最长为28年,最短为3个月,平均病程为12.5年。
按就诊的先后顺序分成二组:治疗组255例、对照组252例,二组在年龄、性别、病程等方面比较无显著性差异(P>0.05),具有可比性。
1.2纳入、排除标准。
就诊时全部病例经症状、体征、X线及理化指标检查确诊为骨关节炎,依据中药新药临床研究指导原则中医辨证为肾虚瘀痹型。停用既往应用治疗骨关节炎药物1个月后方可入组。排除妊娠期或哺乳期妇女;重叠其他风湿系统疾病,合并脑血管、心血管、肝、肾及造血系统等严重原发性疾病;精神病患者;法律规定的残疾患者(盲、聋、哑、智力障碍、精神障碍、肢体残疾);晚期关节炎重度畸形、僵硬、丧失劳动力患者;不能坚持治疗者。
1.3治疗方法。
治疗组给予硫酸氨基葡萄糖500mg日三次口服,联合本实施例1用于贴敷治疗骨关节炎的中药散剂贴敷穴位治疗。对照组给予硫酸氨基葡萄糖500mg日三次口服。两组均在硫酸氨基葡萄糖服用六个月后进行评价。
硫酸氨基葡萄糖商品名为维固力,为罗达药厂生产,进口药品注册号:H20090797。
贴敷穴位选取双侧外关、双侧肾俞、命门、腰阳关、双侧足三里穴共8穴。
穴位贴敷方法:从春分、秋分节气当天开始,隔5天贴敷1次,每次贴敷6-8小时,每个节气贴敷5次。无论首次贴敷是春分,还是秋分,均在两个季节贴敷后(即硫酸氨基葡萄糖口服六个月后)进行评价。
两组患者均避免劳累、寒冷等因素。
2.观察指标。
2.1一般项目:性别、年龄、身高、体重、病程、血压等项目。
2.2疗效指标检测。
A 主要症状、体征。
关节疼痛、肿胀、压痛、胫膝酸软、关节僵硬、最长行走距离、关节屈伸不利、上下楼、下蹲、走不平坦路困难度。
B 对疼痛按简化McGee标尺法评分。
疼痛McGee标尺评分法:该法采用一条10cm的直线或尺,两端标明有0和10的字样,0端代表无痛,10端代表剧烈的疼痛,让患者在直线上或尺上表出自己疼痛的相应位置,然后用尺子测量出疼痛强度的数值或称评分。
C 血沉(ESR)、C反应蛋白(CRP)。
3.疗效评价标准:参照《中药新药治疗骨关节炎的临床研究指导原则》制定。
临床痊愈:症状完全消失,关节功能恢复正常,主要理化检查指标正常,疗效指数均≥95%。
显效:主要症状消失,关节功能基本恢复,主要理化检查指标基本正常,疗效指数为70%-94%。
有效:主要症状基本消失,主要关节功能及主要理化指标有所改善,疗效指数为30%-69%。
无效:与治疗前相比,各方面均无改善,疗效指数<30%。
疗效指数计算公式(尼莫地平法)为:[(治疗前积分-治疗后积分)/治疗前积分]×100%。
4.统计分析:采用SPSS17.0软件包统计,计数资料采用X2检验,疗效指标采用t检验统计学方法处理。
5.结果:治疗组脱落6例,有2例因贴敷过敏脱落,2例胃肠道反应停硫酸氨基葡萄糖(贴敷未停),1例行白内障手术而停药,1例失访;对照组脱落4例,2例胃肠道不适,1例失访,1例自觉血压不稳(只用药1个月);两组患者治疗后安全性指标(血、尿、便常规、肝肾功能、血压)较治疗前比较无异常。
5.1两组临床疗效比较,结果参见表1。
表1:两组临床疗效比较。
两组总疗效经统计学处理,控显率有显著性差异,P<0.01,总有效率有显著性差异,P<0.05。
5.2两组临床疗效比较,结果参见表2。
表2: 两组治疗前后主要症状、体征总积分比较。
两组治疗前后积分均有所减少,经配对样本t检验处理两组均P<0.01,有显著性差异;治疗后治疗组与对照组比较,经独立样本t检验处理P<0.05,有显著性差异,治疗组明显好于对照组。
5.3两组治疗前后疼痛分值的比较,结果参见表3。
表3:两组治疗前后疼痛分值比较。
治疗组治疗后较治疗前比较,P<0.01,有显著性差异;对照组治疗后较治疗前比较,P<0.05,有显著性差异。治疗后治疗组与对照组比较,P<0.05,有显著性差异,治疗组在改善疼痛方面较对照组明显。
5.4两组治疗前后ESR、CRP比较,结果参见表4。
表4:两组治疗前后ESR、CRP比较。
两组治疗前后ESR 的比较,P>0.05,两组均无显著性差异; 治疗后两组比较,P>0.05,无显著性差异。
两组治疗前后CRP的比较,治疗组前后比较,P<0.01,有极显著性差异;对照组前后比较,P<0.05,有显著性差异。两组治疗后CRP比较,P<0.01,有极显著性差异。
综上所述,本发明用于贴敷治疗骨关节炎的中药散剂与硫酸氨基葡萄糖协同控制病情,在改善主要症状、体征,减轻关节疼痛及降低CRP方面有明显疗效,且不良反应少,可以明显减轻病人的痛苦。本次临床研究发现,本发明用于贴敷治疗骨关节炎的中药散剂与硫酸氨基葡萄糖合用具有较好的改善骨关节炎病情作用,疗效优于对照组,说明本发明可获得更好的临床疗效,值得在临床上广泛推广应用。
实施例2。
本实施例提供一种用于贴敷治疗骨关节炎的中药散剂,是由以下重量份数的中药组成的:鹿衔草18份、杜仲15份、续断10份,狗脊13份、补骨脂16份、山茱萸13份、熟地17份、仙茅15份、仙灵脾18份、胡桃肉15份、透骨草25份、姜黄10份、制南星9份、延胡索12份、僵蚕10份、穿山甲12份、当归18份、白芍10份、姜汁25份、麝香0.4份。
实施例3。
本实施例提供一种用于贴敷治疗骨关节炎的中药散剂,是由以下重量份数的中药组成的:鹿衔草20份、杜仲10份、续断15份,狗脊15份、补骨脂20份、山茱萸15份、熟地20份、仙茅10份、仙灵脾20份、胡桃肉10份、透骨草30份、姜黄8份、制南星10份、延胡索15份、僵蚕12份、穿山甲15份、当归20份、白芍15份、姜汁30份、麝香0.5份。
Claims (4)
1.一种用于贴敷治疗骨关节炎的中药散剂,其特征在于,由如下重量份数的原料制成:鹿衔草15~20份、杜仲10~15份、续断10~15份,狗脊10~15份、补骨脂15~20份、山茱萸10~15份、熟地15~20份、仙茅10~15份、仙灵脾15~20份、胡桃肉10~15份、透骨草20~30份、姜黄8~10份、制南星8~10份、延胡索10~15份、僵蚕10~15份、穿山甲10~15份、当归15~20份、白芍10~20份、姜汁20~30份、麝香0.3~0.5份。
2.根据权利要求1所述的一种用于贴敷治疗骨关节炎的中药散剂,其特征在于,由如下重量份数的原料制成:鹿衔草15份、杜仲12份、续断12份,狗脊10份、补骨脂15份、山茱萸10份、熟地15份、仙茅13份、仙灵脾15份、胡桃肉13份、透骨草20份、姜黄9份、制南星8份、延胡索10份、僵蚕15份、穿山甲10份、当归15份、白芍20份、姜汁20份、麝香0.3份。
3.根据权利要求1所述的一种用于贴敷治疗骨关节炎的中药散剂,其特征在于,由如下重量份数的原料制成:鹿衔草18份、杜仲15份、续断10份,狗脊13份、补骨脂16份、山茱萸13份、熟地17份、仙茅15份、仙灵脾18份、胡桃肉15份、透骨草25份、姜黄10份、制南星9份、延胡索12份、僵蚕10份、穿山甲12份、当归18份、白芍10份、姜汁25份、麝香0.4份。
4.根据权利要求1所述的一种用于贴敷治疗骨关节炎的中药散剂,其特征在于,由如下重量份数的原料制成:鹿衔草20份、杜仲10份、续断15份,狗脊15份、补骨脂20份、山茱萸15份、熟地20份、仙茅10份、仙灵脾20份、胡桃肉10份、透骨草30份、姜黄8份、制南星10份、延胡索15份、僵蚕12份、穿山甲15份、当归20份、白芍15份、姜汁30份、麝香0.5份。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610271425.5A CN105944048B (zh) | 2016-04-28 | 2016-04-28 | 一种用于贴敷治疗骨关节炎的中药散剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610271425.5A CN105944048B (zh) | 2016-04-28 | 2016-04-28 | 一种用于贴敷治疗骨关节炎的中药散剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105944048A CN105944048A (zh) | 2016-09-21 |
CN105944048B true CN105944048B (zh) | 2019-11-05 |
Family
ID=56915902
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610271425.5A Expired - Fee Related CN105944048B (zh) | 2016-04-28 | 2016-04-28 | 一种用于贴敷治疗骨关节炎的中药散剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105944048B (zh) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102327380A (zh) * | 2011-10-22 | 2012-01-25 | 李进峰 | 一种治疗膝关节骨性关节炎的中药组合物 |
CN103393840A (zh) * | 2013-07-24 | 2013-11-20 | 赵世明 | 一种治疗骨性关节炎的中药组合物 |
CN103845675A (zh) * | 2012-12-04 | 2014-06-11 | 丁其平 | 一种治疗骨关节病的中药软膏 |
CN104491831A (zh) * | 2015-01-26 | 2015-04-08 | 徐贵星 | 一种治疗致密性骶髂骨关节炎的中药制剂及其制备方法 |
CN104524246A (zh) * | 2015-01-22 | 2015-04-22 | 王雷 | 一种治疗骨关节病的膏药 |
CN105148179A (zh) * | 2015-08-12 | 2015-12-16 | 孙国栋 | 一种治疗膝关节骨性关节炎的外用药物及使用方法 |
-
2016
- 2016-04-28 CN CN201610271425.5A patent/CN105944048B/zh not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102327380A (zh) * | 2011-10-22 | 2012-01-25 | 李进峰 | 一种治疗膝关节骨性关节炎的中药组合物 |
CN103845675A (zh) * | 2012-12-04 | 2014-06-11 | 丁其平 | 一种治疗骨关节病的中药软膏 |
CN103393840A (zh) * | 2013-07-24 | 2013-11-20 | 赵世明 | 一种治疗骨性关节炎的中药组合物 |
CN104524246A (zh) * | 2015-01-22 | 2015-04-22 | 王雷 | 一种治疗骨关节病的膏药 |
CN104491831A (zh) * | 2015-01-26 | 2015-04-08 | 徐贵星 | 一种治疗致密性骶髂骨关节炎的中药制剂及其制备方法 |
CN105148179A (zh) * | 2015-08-12 | 2015-12-16 | 孙国栋 | 一种治疗膝关节骨性关节炎的外用药物及使用方法 |
Non-Patent Citations (2)
Title |
---|
综合治疗膝关节骨性关节炎30例;范世军等;《湖南中医杂志》;20100525;第26卷(第3期);第64-65页 * |
补肾益肝汤治疗骨性关节炎63例报告;文宏修;《中医正骨》;20000930;第51页左栏倒数第1段,右栏倒数第1段 * |
Also Published As
Publication number | Publication date |
---|---|
CN105944048A (zh) | 2016-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101791364B (zh) | 一种促进伤口愈合的药膏及其制备方法 | |
CN101972453B (zh) | 一种治疗风湿类风湿关节炎的中药药酒及其制备方法 | |
CN103705751B (zh) | 用于治疗风湿腰痛的中药组合物及其制备方法 | |
CN104096178A (zh) | 治疗脏腑筋骨疼痛的康复贴 | |
CN101284114A (zh) | 治疗风湿和类风湿疾病的药物 | |
CN103768531B (zh) | 用于治疗类风湿关节炎的中药组合物及其制备方法 | |
CN103285206B (zh) | 一种治疗风湿性关节炎的中药药酒 | |
CN108355065A (zh) | 用于治疗风湿、骨质增生与内科杂症的膏药及其制备方法 | |
CN104815318A (zh) | 一种治疗痛风的中药制剂 | |
CN104548049A (zh) | 一种治疗老年性骨质疏松症的中药组合物及其制备方法 | |
CN105944048B (zh) | 一种用于贴敷治疗骨关节炎的中药散剂 | |
CN103735647A (zh) | 一种治疗类风湿性关节炎的药酒 | |
CN1772245A (zh) | 按摩推拿保健蛇药酒及其应用 | |
CN102512560A (zh) | 一种治疗痹症的中药组合物 | |
CN102600251B (zh) | 一种治疗类风湿关节炎的中药制剂 | |
CN102935156B (zh) | 一种治疗骨质增生症的丸剂 | |
CN109674974A (zh) | 一种补肾固精养元膏药及其制备方法 | |
CN105250933B (zh) | 一种三十六味活血化淤的中药组合物及其膏剂的制备方法 | |
CN103610914B (zh) | 一种治疗风湿性关节炎的内服中药酒 | |
CN100406035C (zh) | 一种治疗腰椎间盘突出症的中药制剂 | |
CN107158265A (zh) | 一种治疗子宫脱垂的中药组合物 | |
CN100435833C (zh) | 治疗痹症的药物及其制备方法 | |
CN106237008A (zh) | 一种治疗腰间盘突出症的药物及其制备方法 | |
CN105902600A (zh) | 一种腰痛灵酒及其制备方法 | |
CN101057915A (zh) | 养肾痛风胶囊 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20191105 |
|
CF01 | Termination of patent right due to non-payment of annual fee |